| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $99.3M | -6.3% |
| SG&A Expense | $28.3M | +6.6% |
| Operating Income | -$127.6M | +16.1% |
| Interest Expense | $4K | -84.0% |
| Pre-tax Income | -$117.1M | +17.9% |
| Income Tax | $0 | — |
| Net Income | -$117.1M | +17.9% |
| EPS (Basic) | -$1.33 | +59.8% |
| EPS (Diluted) | -$1.33 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.5M | -64.6% |
| Current Assets | $180.1M | +11.0% |
| Total Assets | $220.2M | +6.2% |
| Current Liabilities | $19.4M | +0.5% |
| Total Liabilities | $33.6M | -9.5% |
| Stockholders' Equity | $186.6M | +9.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$92.4M | +1.4% |
| Capital Expenditures | $1.1M | -75.0% |
| Investing Cash Flow | -$119.2M | -2571.2% |
| Financing Cash Flow | $111.3M | — |
| Free Cash Flow | -$93.5M | +4.8% |
| +59.8% |